Hypomethylation of repeated elements in the genome is a common feature of human cancer, however, the direct consequences of this epigenetic defect for cancer biology are still largely unknown. Telomeres are specialized chromatin structures at the ends of eukaryotic chromosomes formed by tandem repeats of G-rich sequences and associated proteins, which have an essential role in chromosome end protection and genomic stability. Telomeric DNA repeats cannot be methylated, however, the adjacent subtelomeric DNA is heavily methylated in humans. Here, we show that the methylation status of subtelomeric DNA repeats negatively correlates with telomere length and telomere recombination in a large panel of human cancer cell lines. These findings suggest that tumor telomere length and integrity can be influenced by epigenetic factors. Finally, we show that treatment of human cancer cell lines with demethylating drugs results in hypomethylation of subtelomeric repeats and increased telomere recombination, which in turn may facilitate telomere elongation. All together, these findings suggest that tumor telomere length and integrity can be influenced by the epigenetic status of cancer cells.
Introduction
Global DNA hypomethylation and in particular hypomethylation of DNA repetitive sequences in the genome (subtelomeric and pericentric repeats) are well-known characteristics of human cancer . However, little is known on the direct consequences of these epigenetic defects other than they are associated to loss of acetylation at Lys16 (AcH4K16) and trimethylation at Lys20 of histone 4 (trimH4K20) at these DNA repetitive sequences , suggesting a change in the chromatin structure at these regions towards a less compacted state. Interestingly, global DNA hypomethylation and loss of trymethylation at Lys20 of histone 4 (H4K20) can result from abrogation of the Retinoblastoma family of tumor suppressor proteins, which are frequently mutated in cancer, thus highlighting the potential relevance of these epigenetic defects for cancer biology .
Telomeres are heterochromatic structures at the ends of chromosomes, which in vertebrates consist of tandem repeats of the TTAGGG sequence bound by an array of specialized proteins that form a protective structure known as shelterin (reviewed in Blackburn, 2001; de Lange, 2005; Blasco, 2007) . Telomeres are essential for chromosome end protection (telomere capping) and chromosomal stability (de Lange, 2005) . Next to telomeric repeats are located the so-called subtelomeric repeats, which are also heterochromatic (Gonzalo et al., 2006; Benetti et al., 2007b; reviewed in Blasco, 2007) . In particular, both telomeres and subtelomeres are enriched in histone marks characteristic of constitutive heterochromatin, including trimethylated H4K20 and H3K9, as well as are bound by the heterochromatin protein 1 isoforms (HP1a, HP1b and HP1g) (Garcı´a-Cao et al., 2004; Gonzalo et al., , 2006 Benetti et al., 2007b; reviewed in Blasco, 2007) . In addition, subtelomeric DNA repeats are heavily methylated both in humans and mice (Steinert et al., 2004; Fraga et al., 2005; Gonzalo et al., 2006) . These epigenetic marks at telomeres and subtelomeres are characteristic of a compacted chromatin state, and have been demonstrated to act as negative regulators of telomere length. In particular, abrogation of the corresponding histone methyltransferases and DNA methyltransferases in genetically modified mice, results in abnormally elongated telomeres (Blasco, 2004; Garcı´a-Cao et al., 2002 , 2004 Blasco, 2004; Gonzalo et al., , 2006 Gonzalo and Blasco, 2005; Benetti et al., 2007a) . These findings suggested that the chromatin state at mammalian telomeres and subtelomeres is important for telomere length control. However, evidence for epigenetic factors controlling telomere length in the context of human adult development or during human disease is still lacking.
Mammalian telomeres can be elongated at least by two independent mechanisms. The main mechanism for telomere elongation is the enzyme telomerase (reviewed in Blackburn, 2001; Collins and Mitchell, 2002; Blasco, 2005) . Telomerase is a reverse transcriptase that synthetizes telomere repeats de novo at the chromosome ends (reviewed in Blackburn, 2001; Collins and Mitchell, 2002; Blasco, 2005) and in this way regulates the length of telomeric repeats. An alternative mechanism for telomere elongation is the so-called alternative lengthening of telomeres or ALT mechanism (reviewed in Muntoni and Reddel, 2005) , which relies on homologous recombination events at telomeres (Dunham et al., 2000; Bailey et al., 2004; Bechter et al., 2004) . ALT cells are characterized by long and heterogeneous telomeres, increased telomere recombination frequencies, as well as by the colocalization of telomeres with the PML bodies forming the so-called ALT-associated PML bodies or APBs (reviewed in Dunham et al., 2000; Bechter et al., 2004; Bailey et al., 2004; Muntoni and Reddel, 2005) . Telomerase is undetectable in most somatic tissues with the exception of stem cell compartments and some highly proliferative cell types (reviewed in Flores et al., 2006) , where telomerase levels are not sufficient to prevent the progressive telomere shortening associated with age (Harley et al., 1990; Canela et al., 2007) . In contrast, more than 90% of all types of human tumors have high levels of telomerase activity, where is thought to maintain a minimum length of telomere repeats to sustain tumor growth (reviewed in Shay and Wright, 2006) . Interestingly, those tumors that are telomerase-negative, activate ALT mechanisms (reviewed in Muntoni and Reddel, 2005) , highlighting the importance of telomere length maintenance in cancer growth. Although the mechanisms by which telomerase is upregulated in cancer are starting to be unveiled and generally involve altered expression of oncogenes and tumor suppressor genes (reviewed in Flores et al., 2006; Shay and Wright, 2006) , virtually nothing is known on the mechanisms that activate ALT in cancer cells. In addition, very little is known on what factors other than telomerase activity may regulate telomere length in human tumors (reviewed in Garcia-Aranda et al., 2006; Shay and Wright, 2006) .
To investigate the mechanisms that regulate telomere length in human tumors, we have measured telomerase activity, telomere length, telomere recombination, as well as the methylation status of subtelomeric and pericentric DNA repeats in a large panel of human cancer cell lines of various tissue origins. Expectedly, we found that telomerase activity levels positively correlated with telomere length in human tumors. Strikingly, subtelomeric DNA methylation negatively correlated with telomere length and telomere recombination frequencies. In turn, increased telomere recombination significantly correlated with telomere length, suggesting that both parameters share common molecular pathways. In contrast, telomere recombination and subtelomeric DNA methylation did not correlate with telomerase activity levels, indicating that subtelomeric DNA methylation and telomere recombination operate independently of telomerase activity in maintaining telomere length in human tumors.
All together, these results highlight the importance of subtelomeric DNA methylation in influencing telomere length and telomere recombination in human cancer cells. The cell types that gave origin to the tumor and the different organs affected are also indicated. Next, we studied whether telomere length in these cancer cell lines was correlated to telomerase activity levels. To this end, we measured telomerase activity in each normal and cancer cell line using the telomere repeat amplification protocol (TRAP) assay (Materials and methods section). As controls, normal IMR90 and BJ human cells did not show detectable telomerase activity (Figures 2a and b) . Similarly, the SAOS2 and U2OS ALT cell lines were telomerase-negative ( Figures  2a and b) . For comparative purposes, all TRAP values were expressed as fold-increase compared to the human cancer cell line KG-1a (except for the control cell lines that were telomerase-negative), which showed the lowest telomerase activity levels of the panel (see Figure 2a for quantification and Figure 2b for representative examples of TRAP results). Interestingly, telomerase activity levels showed a significant positive correlation with average telomere length, as well as with the presence of cells with very long telomeres (nuclei with telomeres >6.5 kb; Po0.001 and Po0.01, respectively; Figure 3 ). In turn, telomerase activity levels showed a significant negative correlation with the presence of cells showing very short telomeres (telomeres o2.5 kb; Po0.01; Subtelomeric methylation and human cancer E Vera et al Figure 3 ). All together, these results suggest that telomere length in human tumors positively correlates with the levels of telomerase activity present in the tumors.
Methylation of subtelomeric DNA repeats in human cancer correlates with telomere length To investigate whether global hypomethylation of the cancer genome telomerase activity (au) % nuclei with telomeres <2.5kb Figure 3 Correlation between telomerase activity and telomere length in human cancer cell lines. Linear regression analysis was used to assess the correlation between telomerase activity and telomere length in human cancer cell lines. Telomerase activity positively correlates with mean telomere length (left panel) and the percentage of nuclei with long telomeres (>6.5 kb; right panel). In turn, telomerase activity negatively correlates with percentage of nuclei with short telomeres (o2.5 kb; middle panel). Telomerase activity is expressed as folds-increase relative to KG-1a cells. Linear regression analysis indicated a very significant negative correlation between DNA methylation of subtelomeric D4Z4 repeats and average telomere length in the panel of human cell lines (Po0.01; Figure 5a ). Importantly, a similar tendency was observed when studying an independent subtelomeric repeat, SRH, located at chromosomes 1, 9, 15, 16 and X (almost significant, P ¼ 0.07; Supplementary Figure 1a and b) . In contrast, global DNA methylation and methylation of pericentromeric DNA repeats did not show any significant correlation with telomere length in the same human cell lines (Figures 5b and c) . These results suggest that loss of DNA methylation specifically at subtelomeric repeats but not at other repeated regions of the genome is associated to the presence of long telomeres in human cancer cells.
Methylation of subtelomeric DNA repeats in human cancer does not correlate with telomerase activity It has been previously reported that telomerase activity can be regulated through promoter DNA methylation. In particular, the human telomerase reverse transcriptase TERT gene can be repressed by promoter hypomethylation (Kitagawa et al., 2000; Guilleret and Benhattar, 2003) . To rule out that the observed correlation between DNA methylation and telomere length could be because of changes in telomerase activity as the consequence of altered promoter methylation, we Figure 5 Correlation of telomeric, pericentric and global DNA methylation levels with telomere length in human cancer cell lines. Linear regression analysis was used to test the association between telomere length and subtelomeric (a) pericentric (b) and global (c) DNA methylation. (a) Subtelomeric DNA methylation negatively correlates with mean telomere length (left panel), also reflected by an increase in the percentage of nuclei with very short telomeres (o2.5 kb; middle panel) and with a decrease in the percentage of nuclei with very long telomeres (>6.5 kb; right panel) associated to increased subtelomeric DNA methylation. In contrast, pericentric (b) and global (c) DNA methylation do not influence telomere length.
Subtelomeric methylation and human cancer E Vera et al compared global DNA methylation as well as subtelomeric and pericentric DNA methylation with telomerase activity levels in the panel of human cancer cell lines studied here. As shown in Figure 6 , telomerase activity levels did not show any significant correlation with either global, subtelomeric or pericentric DNA methylation levels. Absence of correlation between subtelomeric DNA methylation and telomerase activity levels was also confirmed when studying an additional subtelomeric region, SRH, located at chromosomes 1, 9, 15, 16 and X (Supplementary Figure 1c) . These results suggest that long telomeres present in cells showing subtelomeric hypomethylation are not likely to be the consequence of changes in telomerase activity.
A significant correlation between subtelomeric DNA repeat hypomethylation and telomere recombination in human cancer Telomeres can be elongated either by telomerase or by the recombination-based ALT mechanism (Muntoni and Reddel, 2005) . To address whether DNA methylation changes in human normal and cancer cell lines correlated with telomere recombination frequencies, we determined the frequency of telomeric sister chromatid exchange (T-SCE) events in the different cell lines studied here using chromosome orientation FISH (CO-FISH) on metaphase spreads (Materials and methods section; Figure 7a for quantification and Figure 7b for representative examples), previously shown to reflect on homologous recombination between telomeric repeats (Bailey et al., 2004; Bechter et al., 2004; Gonzalo et al., 2006) . Two-color CO-FISH with both the leading-strand and lagging-strand telomere probes allowed to unequivocally determine the occurrence of positive T-SCE events (Figure 7b) . Furthermore, in agreement with these T-SCEs representing true recombination events within telomeric repeats, the labeling was unevenly split between both sister telomeres ( Figure 7b ). As control for basal T-SCE levels in normal human cells, we included early passage primary human IMR90 and BJ cells (Figure 7a ). As a positive control for increased T-SCE events, we include the SAOS2 and U2OS human ALT cell lines. As shown in Figure 7a , the majority of human cancer cell lines (14 out of a total of 17) showed significantly increased T-SCE frequencies compared to normal BJ and IMR90 cells, suggesting that increased telomere recombination is a common feature of human cancer. Interestingly, we found a very significant negative correlation between T-SCE Figure 6 Correlation between telomerase activity and DNA methylation levels in cancer human cell lines. Linear regression analysis was used to test the association between telomerase activity, expressed as fold-increase relative to KG-1a cells, and subtelomeric, pericentric, and global DNA methylation. Telomerase activity levels did not correlate with global or domain-specific DNA methylation.
Subtelomeric methylation and human cancer E Vera et al frequencies and the degree of subtelomeric DNA methylation at two independent subtelomeric repeats (D4Z4 and SRH; Po0.01 in Figure 8a for D4Z4 subtelomeric repeats; Po0.05 in Supplementary Figure  1d for SRH subtelomeric repeats). This correlation was also observed when considering global DNA methylation (Po0.05; Figure 8a ), which may reflect on global DNA methylation defects at different genomic regions, including the subtelomeric repeats. In contrast, this correlation was not found for pericentric repeat DNA methylation (P>0.05; Figure 8a ), indicating that T-SCE frequencies specifically correlate with DNA methylation of subtelomeric regions as well as with global DNA methylation levels in human cell lines. A significant positive correlation was also found between the frequency of T-SCE events and the mean telomere length (Po0.05 in Figure 8b ), as well as with percentage of nuclei showing very long telomeres (telomeres >6.5 kb; Po0.05 in Figure 8b ). In turn, a negative correlation was observed between T-SCE and the percentage of cells showing telomeres o2.5 kb (telomeres o2.5 kb; P ¼ 0.05 in Figure 8b ). These results suggest that increased T-SCE frequencies correlate with increased telomere length in human normal and cancer cell lines. In contrast, T-SCE frequencies did not show any significant correlation with telomerase activity (Figure 8c ), suggesting that the long telomeres associated to increased T-SCE frequencies are generated by mechanisms independent of telomerase activity, most likely involving activation of recombination-based ALT pathways. Of notice, we also observed a significant correlation between increased T-SCE frequencies and Subtelomeric methylation and human cancer E Vera et al increased ploidy (Figure 8d) , possibly reflecting on a higher chromosomal instability in cells with increased recombination.
Epithelial carcinomas show hypomethylated subtelomeres and increased telomere recombination compared to lymphoid tumors We addressed whether there were differences in the mechanisms that control telomere length between our panel of cancer cell lines, which correspond to epithelial carcinomas and those that correspond to lymphoid tumors ( Table 1) . As shown in Figure 9a , there were no significant differences in telomerase activity levels between both tumor types, in agreement with the fact that telomerase is an almost universal feature of all types of human tumors (Shay and Wright, 2006) . Interestingly, we observed that epithelial carcinomas show a significantly decreased subtelomeric methylation compared to tumors of lymphoid origin (Po0.05; Figure 9b ). In addition, epithelial carcinomas showed higher T-SCE frequencies than lymphoid tumors (Po0.05; Figure 9c ), in agreement with a causal relationship between subtelomeric hypomethylation Subtelomeric methylation and human cancer E Vera et al and increased telomere recombination. These data suggests that epithelial carcinomas are genetically more unstable than lymphoid tumors, as indicated by an increased telomere recombination.
DNA hypomethylating drugs lead to increased telomere recombination Finally, to directly address whether induction of DNA hypomethylation at subtelomeric regions in human cancer cell lines leads to increased telomere recombination, we determined T-SCE frequencies in two independent human cancer cell lines treated with DNA demethylating agent 5-aza-deoxycitidine (5-aza-dC; Material and methods section). As shown in Figure  10a , 5-aza-dC treatment significantly decreased DNA methylation levels at the D4Z4 subtelomeric repeats in three independent human cancer cell lines studied. DNA methylation at pericentric repeats was also decreased, although the differences only became statistically significant for one of the cells lines (Figure 10a ).
Importantly, 5-aza-dC treatment significantly increased T-SCE events in the cancer cell lines studied ( Figures  10b and c) . These results suggest an impact of epigenetic drugs on telomere length homeostasis in human cancer cells.
Discussion
Dissecting the mechanisms that regulate telomere length in human tumors is of potential great importance to predict the outcome of putative anticancer therapies based on telomerase inhibition. In spite of extensive literature describing telomerase activation in different types and stages of human cancer, the mechanisms that regulate telomere length homeostasis in cancer cells are still far from being understood. We have recently described a HT-QFISH method that allows to generate very accurate telomere length measurements in many human samples at once (Canela et al., 2007) . Using Table 1 for tumor list). (b) A significant decrease in subtelomeric DNA methylation was observed in epithelial carcinomas compared to lymphoid tumors. (c) A significant increase in telomere recombination was observed in epithelial carcinomas compared to lymphoid tumors.
Subtelomeric methylation and human cancer E Vera et al HT-QFISH, we find a highly significant correlation between telomerase activity levels and telomere length in a large panel of human cancer cell lines. Importantly, we also find significant correlations between epigenetic alterations at telomeric regions and both telomere length and telomere recombination frequencies in human cancer cells. In particular, we make the unprecedented finding that methylation of subtelomeric DNA repeats negatively correlates both with tumor telomere length and with telomere recombination, but not with telomerase activity. Interestingly, telomere recombination is associated to activation of telomerase-independent alternative mechanisms of telomere elongation (ALT), which have been described to operate in a percentage of human cancers (Shay and Wright, 2006) . All together, the results presented here suggest that telomere length in human cancer is influenced both by telomerase activity levels as well as by the DNA methylation status of subtelomeric repeats. Note that in all cases, a T-SCE event was only considered positive when it was observed both at the lagging-and leading-strand telomeres as an unequal exchange of telomeric signal.
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The findings described here are of relevance to determine the biological impact of anticancer therapies based on hypomethylating drugs. In particular, anticancer treatments based on hypomethylating drugs may unleash telomere recombination frequencies in cancer cells, as demonstrated here for 5-aza-dC treatment of various human cancer cell lines. In turn, increased telomere recombination may favor activation of telomere elongation mechanisms independent of telomerase activity, therefore allowing cancer growth. Finally, these effects of loss of DNA methylation at subtelomeric repeats may hamper the efficacy of potential telomerase inhibitors. 
Materials and methods

Cell culture
Highthroughput Q-FISH
For HT-QFISH, we used the cell lines described above. HT-QFISH was performed as previously described (Canela et al., . Images were captured and analysed for each well as described (Canela et al., 2007) . At least 160 cells were analysed for each cell line. The 4 0 ,6-diamidino-2-phenylindole channel was used for nucleus staining and the CY3 for telomere detection. Variations in nuclear size between the different cell lines were corrected. To that end, the 'sum intensity' (rather than average intensity) for each nucleus was calculated by multiplying the average intensity in the nucleus (measured in arbitrary units of fluorescent, a.u.f.) by its area (measured in pixels). The 'background sum intensity' of each nucleus was calculated by multiplying the average intensity of a small ring surrounding the nucleus by the nucleus area, and subtracted to the corresponding 'sum intensity' value. Finally, fluorescence intensities were converted into kb by using HeLa 1211 as calibration standard, which has a stable telomere length of 17.07 kb (Canela et al., 2007) .
Telomerase assay
Telomerase activity was measured with a modified TRAP (Garcı´a-Cao et al., 2002) . As control for PCR efficiency, an internal control (IC) was included in each reaction (TRAPeze kit, Oncor). TRAP gels were autographed with Kodak BioMax films (Kodak) for illustrative purposes. For quantification, TRAP gels were exposed in a Phospor Screen (Molecular Dynamics, Sunnyvale, CA, USA) and visualized on a Storm 820 Phosphorimager (Molecular Dynamics). Digitalized images were quantified by using ImageQuant software (Molecular Dynamics). The 'sum intensity' was calculated for each lane and normalized by the dilution factor of the extract. Telomerase activity values, expressed in arbitrary units (a.u.), were normalized between experiments using the 'sum intensity' values of the MDA-MB-231 cell line included in all experiments and expressed as folds relative to the KG-1a cell line.
Chromosome orientation FISH Confluent human cell lines were subcultured in the presence of 5 0 -bromo-2 0 -deoxyuridine (BrdU; Sigma) at a final concentration of 1 Â 10 -5 M at 37 1C during sufficient time to allow one round of replication (this time was variable for different cell lines). Colcemid was added at a concentration of 0.2 mg/ml for the last 4 h of incubation. Cells were recovered and metaphase spreads prepared as described for Q-FISH (Samper et al., 2000) . CO-FISH was performed as previously described (Bailey et al., 2001; Gonzalo et al., 2006) , using first a (CCCTAA) 3 PNA probe labeled with Cy3 and then a second (TTAGGG) 3 PNA labeled with Flurescein (Applied Biosystems, Foster City, CA, USA). Metaphase spreads were captured on a Leitz Leica DMRB fluorescence microscope. Normal human BJ fibroblasts were included in each experiment as a control for basal levels of T-SCE, as well as to normalize between different experiments.
Quantification of total DNA methylation 5-Methylcytosine (5-mC) genomic content was determined by high-performance capillary electrophoresis, as previously described (Fraga et al., 2002) . Briefly, genomic DNA samples were boiled, treated with nuclease P1 (Sigma) for 16 h at 37 1C, and with alkaline phosphatase (Sigma) for an additional 2 h at 37 1C. After hydrolysis, total cytosine and 5-mC content were measured by capillary electrophoresis using a P/ACE MDQ system (Beckman-Coulter). Relative 5-mC content was expressed as a percentage of total cytosine content (methylated and non-methylated).
Analysis of sequence-specific DNA methylation The CpG methylation status of the subtelomeric repeat D4Z4 (chromosome 4q35) and the pericentric repeat NBL2 (chromosomes 9, 13, 14 and 21; Kondo et al., 2000) was established after bisulfite modification of the genomic DNA (Herman et al., 1996) . Bisulfite genomic sequencing of multiple clones was then carried out as described elsewhere . The primers used to amply the bisulfite modified DNA were: D4Z4 forward, 5 0 -GTTTGTTGTTGGATGAGTTT TTGG-3 0 and reverse, 5 0 -AAATCTCTCACCRAACCTAAA CC-3 0 ; NBL2 forward, 5 0 -GTAGTTGGTGTTAATGTGTG TTAT-3 0 and reverse 5 0 -CACTCTCTATATATTTCTTTC CC-3 0 . Automatic sequencing of 10 colonies for each sequence was performed to obtain statistical data on the methylation status of every single CpG.
An additional subtelomeric repeat SRH (5 0 -Chr1, 5 0 -Chr9 0 , 3 0 -Chr15, 5 0 -Chr16 and 3 0 -ChrX) was analysed to confirm the results obtained with the subtelomeric D4Z4 repeats. The primers used to amply the bisulfite modified DNA were: SRH forward, 5 0 -GTTTGTTGTTGGATGAGTTTTTGG-3 0 and reverse.
Cell cycle analysis for ploidy determination Cells were collected, washed in phosphate-buffered saline (PBS), fixed and permeabilized in 70% ethanol and stored at À20 1C. To determine DNA content, fixed cells were then washed twice in PBS and stained for 30 min at 37 1C with 20 mg/ml propidium iodide and 100 mg/ml RNase A in PBS. Data were collected using a FACScan flow cytometer and CellQuest software (BD Biosciences). For each sample, 10 000 events were collected excluding cell aggregates.
Demethylation assay and CO-FISH Cells were treated for 72 h with 5 mM 5-aza-dC (Sigma). In the last 24 h BrdU was added and CO-FISH was carried out as described previously.
Statistical analysis w
2
-Test was used to calculate the statistical significance of the observed differences in T-SCE. This test was also used to assess the statistical significance of demethylation of D4Z4 and NBL2 repeats by 5-aza-dC. Statgraphic Plus 5.1 was used to perform the statistical analysis.
Linear regression analyses were performed to test the statistical significance of the linear association between the different variables. Statgraphic Plus 5.1 was used to perform the statistical analysis.
In all cases, differences are significant for Po0.05; very significant for Po0.01; highly significant for Po0.001 and extremely significant for Po0.0001.
